GUARDIAN (NCT04884802) Sub-study, Phenylephrine v. Norepinephrine
Status:
Enrolling by invitation
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
Some patients participating in the underlying GUARDIAN trial (NCT04884802) will be
additionally randomized to norepinephrine or phenylephrine infusion to maintain the
designated target intraoperative mean arterial pressure.